Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03177265 · ClinicalTrials.gov registry record · NA
Text Messaging to Engage and Retain Veterans in Smoking Cessation Counseling
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 432
- Enrollment target
NCT03177265: Completed NA study, sponsored by VA Office of Research and Development.
NCT03177265 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 432 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03177265, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 432 participants
- Enrollment target
Study Summary
Tobacco-related diseases account for a significant portion of all VA healthcare costs and are a detriment to the health and quality of life of our Veterans. Despite progress in instituting tobacco screenings and treatment referral, most Veterans still do not receive the most effective strategy to help them quit smoking - pharmacotherapy combined with behavioral coaching. This study builds on findings from population health and mobile interventions to help more Veterans receive evidence-based tobacco treatment. The investigators propose to test the effect of two types of text messaging in combination with telephone cessation counseling: 1) pre-counseling text messages to increase enrollment in counseling, and 2) ongoing texts for those who start counseling that provide appointment reminders and support between sessions to increase adherence to counseling. This study supports multiple goals of the VA's Blueprint for Excellence. Results will directly inform decision-making and population-based care models for tobacco treatment.
Interventions
- BEHAVIORAL Telephone Counseling
- BEHAVIORAL Text messaging prior to first counseling call
- BEHAVIORAL Text-to-Enhance
- BEHAVIORAL Mail Notice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 432 participants |
| Start Date | 2018-11-08 |
| Est. Completion | 2021-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03177265
The ClinicalTrials.gov registry entry for NCT03177265 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 432 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Telephone Counseling is the first listed.
NCT03177265 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03177265 about?
NCT03177265 is a clinical study titled "Text Messaging to Engage and Retain Veterans in Smoking Cessation Counseling". Tobacco-related diseases account for a significant portion of all VA healthcare costs and are a detriment to the health and quality of life of our Veterans. Despite progress in instituting tobacco screenings and treatment referral, most Veterans still do not receive the most effective strategy to he...
What is the current status of trial NCT03177265?
This trial is currently completed. It is a NA study. The enrollment target is 432 participants. The study started on 2018-11-08. Estimated completion is 2021-11-01.
What interventions are being tested in trial NCT03177265?
The interventions under investigation include: Telephone Counseling (BEHAVIORAL), Text messaging prior to first counseling call (BEHAVIORAL), Text-to-Enhance (BEHAVIORAL), Mail Notice (BEHAVIORAL).
Who is sponsoring clinical trial NCT03177265?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.